Concerning the CYP17 MspA1 polymorphism and breast cancer risk: A meta-analysis (multiple letters)

Mutagenesis

Volumn 17, Issue 5, 2002, Pages 445-446

  Feigelson, Heather Spencer ^a   McKean Cowdin, Roberta ^b   Henderson, Brian E ^a  

^a AMERICAN CANCER SOCIETY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYP1 PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ALLELE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; HUMAN; LETTER; MEDICAL LITERATURE; META ANALYSIS; METHODOLOGY; ONCOGENE; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL ANALYSIS;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; META-ANALYSIS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK FACTORS; STEROID 17-ALPHA-HYDROXYLASE;

EID: 0036735190     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (0)